Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P05412 (
c-Jun
)
11,453
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
B cell receptor (BCR) cross-linking induces B cell proliferation and sustains survival through the phosphorylation-dependent signals. We report that a loss of the protein phosphatase component
G5PR
increased the activation-induced cell death (AICD) and thus impaired B cell survival.
G5PR
associates with GANP, whose expression is up-regulated in mature B cells of the peripheral lymphoid organs. To study
G5PR
function, the
G5pr
gene was conditionally targeted with the CD19-Cre combination (
G5pr
(-/-) mice). The
G5pr
(-/-) mice had a decreased number of splenic B cells (60% of the controls).
G5pr
(-/-) B cells showed a normal proliferative response to lipopolysaccharide or anti-CD40 antibody stimulation but not to BCR cross-linking with or without IL-4 in vitro.
G5pr
(-/-) B cells did not show abnormalities in the BCR-mediated activation of Erks and NF-kappaB, cyclin D2 induction, or Akt activation. However,
G5pr
(-/-) B cells were sensitive to AICD caused by BCR cross-linking. This was associated with an increased depolarization of the mitochondrial membrane and the enhanced activation of
c-Jun
NH(2)-terminal protein kinase and Bim. These results suggest that
G5PR
is required for the BCR-mediated proliferation associated with the prevention of AICD in mature B cells.
...
PMID:Protein phosphatase subunit G5PR is needed for inhibition of B cell receptor-induced apoptosis. 1612 5